Research ArticleOriginal Article
Open Access

Safety and efficacy of transthoracic versus transesophageal echocardiography in transcatheter closure of atrial septal defects

Reporting a single center experience from Saudi Arabia

Ahmad S. Azhar
Saudi Medical Journal November 2016, 37 (11) 1196-1205; DOI: https://doi.org/10.15537/smj.2016.11.15617

References

  1. ↵
    1. Maragiannis D,
    2. Little SH
    (2014) Interventional imaging: the role of echocardiography. Methodist Debakey Cardiovasc J 10:172–177.
    OpenUrl
  2. ↵
    1. Lardhi AA
    (2010) Prevalence and clinical significance of heart murmurs detected in routine neonatal examination. J Saudi Hear Assoc 22:25–27.
    OpenUrl
  3. ↵
    1. van der Linde D,
    2. Konings EEM,
    3. Slager MA,
    4. Witsenburg M,
    5. Helbing WA,
    6. Takkenberg JJM,
    7. et al.
    (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 15:58, 2241–2247.
    OpenUrl
  4. ↵
    1. Carlson KM,
    2. Justino H,
    3. O’Brien RE,
    4. Dimas VV,
    5. Leonard GT,
    6. Pignatelli RH,
    7. et al.
    (2005) Transcatheter atrial septal defect closure: modified balloon sizing technique to avoid overstretching the defect and oversizing the Amplatzer septal occluder. Catheter Cardiovasc Interv 66:390–396.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Rana BS,
    2. Shapiro LM,
    3. McCarthy KP,
    4. Ho SY
    (2010) Three-dimensional imaging of the atrial septum and patent foramen ovale anatomy: defining the morphological phenotypes of patent foramen ovale. Eur J Echocardiogr 11:i19–i25.
    OpenUrlCrossRef
  6. ↵
    1. Abaci A,
    2. Unlu S,
    3. Alsancak Y,
    4. Kaya U,
    5. Sezenoz B
    (2013) Short and long term complications of device closure of atrial septal defect and patent foramen ovale: Meta-analysis of 28,142 patients from 203 studies. Catheter Cardiovasc Interv 82:1123–1138.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Yared K,
    2. Baggish AL,
    3. Solis J,
    4. Durst R,
    5. Passeri JJ,
    6. Palacios IF,
    7. et al.
    (2009) Echocardiographic assessment of percutaneous patent foramen ovale and atrial septal defect closure complications. Circ Cardiovasc Imaging 2:141–149.
    OpenUrlFREE Full Text
  8. ↵
    1. Sahin M,
    2. Özkutlu S,
    3. Y\ild\ir\im I,
    4. Karagöz T,
    5. Çeliker A
    (2011) Transcatheter closure of atrial septal defects with transthoracic echocardiography. Cardiol Young 21:204–208.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Zaqout M,
    2. Suys B,
    3. De Wilde H,
    4. De Wolf D
    (2009) Transthoracic echocardiography guidance of transcatheter atrial septal defect closure in children. Pediatr Cardiol Springer 30:992–924.
    OpenUrl
  10. ↵
    1. Li GS,
    2. Kong GM,
    3. Wang YL,
    4. Jin YP,
    5. Ji QS,
    6. Li JF,
    7. et al.
    (2009) Safety and efficacy of transcatheter closure of atrial septal defects guided by transthoracic echocardiography: a prospective study from two Chinese Medical Centers. Ultrasound Med Biol 35:58–64.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Ding C,
    2. Chang JK,
    3. Lin CC,
    4. Wu YJ,
    5. Hsieh KS
    (2016) Efficacy and Safety of Transthoracic Echocardiography Alone in Transcatheter Closure of Secundum-Type Atrial Septal Defects in Adults. Echocardiography 33:579–585.
    OpenUrl
  12. ↵
    1. Warnes CA,
    2. Williams RG,
    3. Bashore TM,
    4. Child JS,
    5. Connolly HM,
    6. Dearani JA,
    7. et al.
    (2008) ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of A. J Am Coll Cardiol, 52e143–e263.
  13. ↵
    1. St. Jude Medical. AMPLATZER®Atrial Septal Occluder Executive Summary
    (2012) U.S. Food and Drug Administration, Available from: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/medicaldevices/medicaldevicesadvisorycommittee/circulatorysystemdevicespanel/ucm304944.pdf, p 35. cited 2016 Apr 6.
  14. ↵
    1. Bartakian S,
    2. El-Said HG,
    3. Printz B,
    4. Moore JW
    (2013) Prospective randomized trial of transthoracic echocardiography versus transesophageal echocardiography for assessment and guidance of transcatheter closure of atrial septal defects in children using the amplatzer septal occluder. JACC Cardiovasc Interv 6:974–980.
    OpenUrlCrossRef
  15. ↵
    1. Newton A,
    2. Fitton L
    (2008) Intravenous ketamine for adult procedural sedation in the emergency department: a prospective cohort study. Emerg Med J 25:498–501.
    OpenUrlAbstract/FREE Full Text
    1. Dallimore D,
    2. Herd DW,
    3. Short T,
    4. Anderson BJ
    (2008) Dosing ketamine for pediatric procedural sedation in the emergency department. Pediatr Emerg Care 24:529–533.
    OpenUrlPubMed
  17. ↵
    1. Gozal D,
    2. Mason KP
    (2010) Pediatric sedation: a global challenge. Int J Pediatr 2010:701257.
    OpenUrlPubMed
  18. ↵
    1. Hijazi ZM
    (2011) Device closure of secundum atrial septal defects: to balloon size or not to balloon size. Ann Pediatr Cardiol 4:34–35.
    OpenUrlPubMed
  19. ↵
    1. Vijarnsorn C,
    2. Durongpisitkul K,
    3. Chanthong P,
    4. Chungsomprasong P,
    5. Soongswang J,
    6. Loahaprasitiporn D,
    7. et al.
    (2012) Transcatheter closure of atrial septal defects in children, middle-aged adults, and older adults: failure rates, early complications; and balloon sizing effects. Cardiol Res Pract 2012:584236.
    OpenUrlPubMed
  20. ↵
    1. Moore J,
    2. Hegde S,
    3. El-Said H,
    4. Beekman R,
    5. Benson L,
    6. Bergersen L,
    7. et al.
    (2013) Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv 6:433–442.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Behjati M,
    2. Mirhosseini S-J,
    3. Hosseini S-H,
    4. Rajaei S
    (2011) Transcatheter closure of atrial septal defect with Amplatzer device in children and adolescents: short and midterm results;an Iranian experience. Iran J Pediatr 21:166–172.
    OpenUrlPubMed
  22. ↵
    1. Kardon RE,
    2. Sokoloski MC,
    3. Levi DS,
    4. Perry JS,
    5. Schneider DJ,
    6. Allada V,
    7. et al.
    (2004) Transthoracic echocardiographic guidance of transcatheter atrial septal defect closure. Am J Cardiol 15(94):256–260.
    OpenUrl
  23. ↵
    1. Aytemir K,
    2. Oto A,
    3. Özkutlu S,
    4. Canpolat U,
    5. Kaya EB,
    6. Yorgun H,
    7. et al.
    (2013) Transcatheter Interatrial Septal Defect Closure in a Large Cohort: Midterm Follow-up Results. Congenit Heart Dis 8:418–427.
    OpenUrl
  24. ↵
    1. Chen Q,
    2. Cao H,
    3. Zhang G-C,
    4. Chen L-W,
    5. Chen D-Z
    (2015) Safety and feasibility of intra-operative device closure of atrial septal defect with transthoracic minimal invasion. Eur J Cardiothorac Surg 41:121–125.
    OpenUrl
  25. ↵
    1. Ji Q,
    2. Mei Y,
    3. Wang X,
    4. Feng J,
    5. Cai J,
    6. Ding W
    (2013) Risk factors for pulmonary complications following cardiac surgery with cardiopulmonary bypass. Int J Med Sci 10:1578–1583.
    OpenUrl
  26. ↵
    1. Huffmyer JL,
    2. Groves DS
    (2015) Pulmonary complications of cardiopulmonary bypass. Best Pract Res Clin Anaesthesiol 29:163–175.
    OpenUrl
  27. ↵
    1. Butera G,
    2. Biondi-Zoccai G,
    3. Sangiorgi G,
    4. Abella R,
    5. Giamberti A,
    6. Bussadori C,
    7. et al.
    (2011) Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. EuroIntervention 7:377–385.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Geva T,
    2. Martins JD,
    3. Wald RM
    (2014) Atrial septal defects. Lancet 383:1921–1932.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. da Costa MGS,
    2. da Silva Santos M,
    3. Sarti FM,
    4. Senna MS,
    5. Tura BR,
    6. Goulart MC
    (2014) Cost-effectiveness of procedures for treatment of ostium secundum atrial septal defects occlusion comparing conventional surgery and septal percutaneous implant. PLoS One 9:10.
    OpenUrlCrossRef
  30. ↵
    1. Chen X,
    2. Chenna V,
    3. Maitra A,
    4. Devaraj S
    (2014) Nanocurcumin attenuates inflammation by decreasing Toll-like receptor 2 and 4 expression and activity and promoting an anti-inflammatory macrophage phenotype (830.22). FASEB J 28:822–830.
    OpenUrl
  31. ↵
    1. Putra ST,
    2. Djer MM,
    3. Idris NS,
    4. Samion H,
    5. Sastroasmoro S
    (2015) Transcatheter Closure of Atrial Septal Defects in a Center With Limited Resources: Outcomes and Short Term Follow-Up. Iran J Pediatr 25:6.
    OpenUrl
  32. ↵
    1. Hijazi ZM,
    2. Shivkumar K,
    3. Sahn DJ
    (2009) Intracardiac echocardiography during interventional and electrophysiological cardiac catheterization. Circulation. Am Heart Assoc 119:587–596.
    OpenUrl
  33. ↵
    1. Saksena S,
    2. Sra J,
    3. Jordaens L,
    4. Kusumoto F,
    5. Knight B,
    6. Natale A,
    7. et al.
    (2010) A prospective comparison of cardiac imaging using intracardiac echocardiography with transesophageal echocardiography in patients with atrial fibrillation the intracardiac echocardiography guided cardioversion helps interventional procedures study. Circ Arrhythm Electrophysiol 3:571–577.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section